Ignite Creation Date:
2024-05-06 @ 3:52 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02393794
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-27
First Post:
2015-03-13
Brief Title:
Cisplatin Plus Romidepsin Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer TNBC
Sponsor:
Priyanka Sharma
Organization:
University of Kansas Medical Center
Organization Data
Organization:
University of Kansas Medical Center
Class:
OTHER
Study ID:
IIT-2014-CISRomiNivoTNBC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Priyanka Sharma
Lead Sponsor Class:
OTHER
Responsible Party:
Priyanka Sharma
Responsible Party Title:
Associate Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Kansas Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |
| Celgene Corporation | INDUSTRY |